All News

Due to lack of data on menopause and HIV, many women living with HIV infection have limited access to medical care and support.

The FDA has programs designed to expedite the drug development and review processes for promising pipeline products. The newest of these programs is Regenerative Medicine Advanced Therapy (RMAT).

Recently, Facebook was in the spotlight for trying to share patient data with health organizations.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

More action is needed to address health disparities, risk factors, and social determinants of health, as well as disease prevention.

Reported deaths of Parkinson’s patients treated with Acadia Pharmaceutical’s antipsychotic therapy pimavanserin (Nuplazid) has sparked concern.

After completing a drug information residency and serving as a pharmacy professor, I knew that the next chapter of my life would be dedicated to being a parent.

US report indicates new drivers of death have emerged over time and have continued to unequally affect residents at the state level.

The therapy is a combination of a checkpoint drug, nivolumab, and a new immune stimulation drug, ALT-803.

New drug shows promising signs of delaying the development of existing breast and lung cancers. .

Here are some top pharmacy concerns and 2 hilarious ways to answer.

Let's get to know this very popular social-media phenomenon.

This is the sixth part of a series on how pharmacy professionals have been depicted on TV, both in a positive and a negative manner.

The approval follows a review of scientific evidence, including a clinical study of 24 patients that evaluated daytime and nighttime driving performance while wearing the lenses.

Medication use in horse racing has become a hot topic across the country.

The triple combination includes a novel cystic fibrosis transmembrane conductance regulator amplifier, third generation corrector, and potentiator.

Three deaths are among 107 reported incidences of individuals who experienced severe bleeding after using synthetic cannabinoids.

Pediatric patients treated with larotrectinib in a clinical trial demonstrated a 93% response rate.

An experimental program in Maryland aimed to reduce health care spending by shifting away from hospital-based care and toward less costly, primary, preventive, and outpatient services.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

FDA to limit distribution of Bayer’s Essure device to guarantee women considering permanent contraception are provided with adequate risk information.

Bupivacaine liposome injectable suspension (Exparel) is the first long-acting, single-dose nerve block for patients undergoing upper extremity surgeries.

Upadacitinib met primary endpoints of ACR20 and clinical remission versus placebo in treatment of moderate to severe rheumatoid arthritis.

The FDA recently released a warning for a company whose business is focused on creating online prescriptions for patients doing a home vision test. But the concern is that this is a medical device, which never got clearance.

Advancing therapies have resulted in more women living with HIV who experience menopause. Unfortunately, many WLHIV fall into a knowledge gap.

Getting rid of the needle in injectables has been in the talks for awhile, but Takeda is trying to make it a reality.

Top news of the day from across the health care landscape.

Pharmacists can help optimize medication regimens to produce the best patient outcomes at the lowest cost.